S. 1802 (119th)Bill Overview

CARGO Act of 2025

Health|Health
Cosponsors
Support
Lean Republican
Introduced
May 19, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill amends the Public Health Service Act to prohibit the National Institutes of Health from funding any research activity or program that uses live animals unless that research takes place within the United States. "United States" is defined to include States, territories, and possessions. The bill is motivated by findings about historical NIH funding to foreign organizations and concerns about oversight and animal welfare.

Why people may split

Liberals stress global health collaboration harms; conservatives stress stopping taxpayer-funded overseas experiments

Watch point

Relative to its intended legislative type, this bill is a straightforward substantive policy change that clearly states a prohibition on NIH support for live-animal research conducted outside the United States and cites supporting findings.

This bill amends the Public Health Service Act to prohibit the National Institutes of Health from funding any research activity or program that uses live animals unless that research takes place within the United States. "United States" is defined to include States, territories, and possessions.

The bill is motivated by findings about historical NIH funding to foreign organizations and concerns about oversight and animal welfare.

Passage25/100

Clear, restrictive policy with limited compromise features and strong organized opposition from scientific and international stakeholders reduces prospects.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a straightforward substantive policy change that clearly states a prohibition on NIH support for live-animal research conducted outside the United States and cites supporting findings. It is explicit about the prohibited funding instruments and the statutory insertion point.

Contention55/100

Liberals stress global health collaboration harms; conservatives stress stopping taxpayer-funded overseas experiments

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
TaxpayersWorkers

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitImproves animal welfare by channeling funded animal research into U.S.-inspected facilities.
  • TaxpayersIncreases NIH oversight and inspection ability for taxpayer-funded animal research.
  • TaxpayersReduces risk that taxpayer dollars support research in jurisdictions with weaker welfare reporting.
Likely burdened
  • WorkersDisrupts international collaborations and multisite studies that rely on overseas animal work.
  • Potential burdenCould slow preclinical research timelines by eliminating access to specialized foreign models or facilities.
  • Potential burdenIncreases research costs because U.S. facilities generally have higher operating and compliance expenses.
03 · Why people split

Why the argument around this bill splits.

Liberals stress global health collaboration harms; conservatives stress stopping taxpayer-funded overseas experiments
Progressive55%

Likely sympathetic to the animal welfare rationale but concerned about blunt impacts on global health research and equity.

Prefers stronger oversight, alternatives to animal use, and careful transition measures rather than an absolute ban.

Split reaction
Centrist45%

Views the oversight concerns as legitimate but sees the ban as overly broad and possibly counterproductive.

Would favor targeted reforms, verification requirements, or conditional exceptions instead of an outright prohibition.

Split reaction
Conservative65%

Likely supportive because it prevents U.S. taxpayer money funding animal research overseas and asserts national control.

Some concern exists about harming U.S. scientific competitiveness, but many conservatives favor restricting federal funding abroad.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood25/100

Clear, restrictive policy with limited compromise features and strong organized opposition from scientific and international stakeholders reduces prospects.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • No official cost estimate or budgetary analysis provided
  • How NIH would verify location/compliance and enforce prohibition
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals stress global health collaboration harms; conservatives stress stopping taxpayer-funded overseas experiments

Clear, restrictive policy with limited compromise features and strong organized opposition from scientific and international stakeholders r…

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward substantive policy change that clearly states a prohibition on NIH support for live-animal research conducted outside the United States and cites…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis